Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500096869Phase 4Not yet recruiting
Phase 4, randomised trial in procedural pain and procedural sedation and analgesia (PSA) comparing Oliceridine + propofol with Fentanyl + propofol (2 arms). Primary endpoint: Incidence of SpO2 < 95% or respiratory rate < 10 breaths/min. Planned start Feb 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500096869.